MitraClip NT System Post-marketing Surveillance Study - Japan
NCT ID: NCT03500692
Last Updated: 2024-07-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2018-04-02
2022-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MitraClip for Severe TR
NCT02863549
Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery
NCT01431222
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
NCT03433274
Valveclip® Transcatheter Mitral Valve Repair Study
NCT05021614
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
NCT01931956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be evaluated at Baseline, Procedure, Discharge, 30 days, 1 year, 2 years and 3 years in Japanese medical centers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MitraClip NT System
Percutaneous mitral valve repair using MitraClip NT System
MitraClip NT System
Percutaneous mitral valve repair using MitraClip NT System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MitraClip NT System
Percutaneous mitral valve repair using MitraClip NT System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria: Refer to MitraClip IFU
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nagoya Heart Center
Nagoya, Aichi-ken, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan
New Tokyo Hospital
Matsudo, Chiba, Japan
Tokyo Bay Urayasu Ichikawa Medical Center
Urayasu, Chiba, Japan
Ehime Prefectural Central Hospital
Matsuyama, Ehime, Japan
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
Kokura Memorial Hospital
Kitakyushu, Fukuoka, Japan
Asahikawa Medical University Hospital
Asahikawa, Hokkaido, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Hyogo Prefectural Amagasaki General Medical Center
Amagasaki, Hyōgo, Japan
Hyogo Brain and Heart Center
Himeji, Hyōgo, Japan
University of Tsukuba Hospital
Tsukuba, Ibaraki, Japan
Iwate Medical University Hospital
Morioka, Iwate, Japan
Tokai University Hospital
Isehara, Kanagawa, Japan
Shonan Kamakura General Hospital
Kamakura, Kanagawa, Japan
St. Marianna Medical University Hospital
Kawasaki, Kanagawa, Japan
Saiseikai Yokohamashi Tobu Hospital
Yokohama, Kanagawa, Japan
Saiseikai Kumamoto Hospital
Kumamoto, Kumamoto, Japan
University Hospital Kyoto Prefectural University of Medicine
Kyoto, Kyoto, Japan
Sendai Kousei Hospital
Sendai, Miyagi, Japan
Miyazaki Medical Association Hospital
Miyazaki, Miyazaki, Japan
Kurashiki Central Hospital
Kurashiki, Okayama-ken, Japan
The Sakakibara Heart Institute of Okayama
Okayama, Okayama-ken, Japan
Kishiwada Tokushukai Hospital
Kishiwada, Osaka, Japan
Osaka City University Hospital
Osaka, Osaka, Japan
Osaka General Medical Center
Osaka, Osaka, Japan
Osaka University Hospital
Suita-shi, Osaka, Japan
National Cerebral and Cardiovascular Center
Suita-shi, Osaka, Japan
Saitama Medical University International Medical Center
Hidaka, Saitama, Japan
Shizuoka General Hospital
Shizuoka, Shizuoka, Japan
Juntendo University Hospital
Bunkyo, Tokyo, Japan
The University of Tokyo Hospital
Bunkyo, Tokyo, Japan
Mitsui Memorial Hospital
Chiyoda City, Tokyo, Japan
Sakakibara Heart Institute
Fuchū, Tokyo, Japan
Keio University Hospital
Shinjuku-Ku, Tokyo, Japan
Tokyo Women's Medical University Hospital
Shinjuku-Ku, Tokyo, Japan
Teikyo University Hospital
tabashi City, Tokyo, Japan
Tottori University Hospital
Yonago, Tottori, Japan
Toyama University Hospital
Toyama, Toyama, Japan
Tokushima Red Cross Hospital
Tokushima, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-519
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.